Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-02

Clinical Trial Update: RHD Genotype Matched Red Cells for Anti-D [EARLY_Phase 1]

View source ↗

Summary

Early Phase 1 trial evaluating RHD genotype-matched red blood cells to mitigate Anti-D antibody reactions in sickle cell disease; the study has completed and re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RHD genotype-matched red blood cells

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Sickle Cell Disease, Anti-D Antibodies | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2025-05-02